Manufacturing

Pharma

AbbVie locks in US pricing deal as it pledges $100B investment

Though not the first pharma to strike a U.S. pricing deal, AbbVie’s new accord is notable for the sheer size of the investment pledge that comes with.

Fraiser Kansteiner Jan 13, 2026 9:15am

Cellares expands to Europe with new facility in the Netherlands

Jan 12, 2026 2:24pm

AbbVie snaps up device plant amid broader $10B US investment

Jan 12, 2026 9:17am

Orca rides $250M funding wave toward cancer cell therapy launch

Jan 9, 2026 11:19am

J&J reveals US drug pricing deal and plans to build 2 US plants

Jan 9, 2026 10:49am

Novartis charts next US investment with new radiopharma plant

Jan 9, 2026 10:30am